Precision Fermentation and Biotechnology in the HMO Infant Formula...

ha aggiunto una foto Altre informazioni

2026-07-29 09:39:21 -

Precision Fermentation and Biotechnology in the HMO Infant Formula Market: Technology Roadmap and Forecast (2026–2033)

According to the latest report published by Data Bridge Market Research, the Human Milk Oligosaccharides (HMOs) in Infant Formula Market Data Bridge Market Research analyses that the human milk oligosaccharides (HMOs) in infant formula market is expected to reach USD 540.12 billion by 2030, which is USD 115.24 billion in 2022, registering a CAGR of 21.30% during the forecast...

0 Commenti 0 condivisioni 18 Views 0 Anteprima